1.1 Background of Alzheimer's disease Alzheimer's disease (AD) is a neurodegenerative
disorder, first presented by the German physician Alois Alzheimer in 1906. In the 4 …

Abstract Background Late stage Alzheimer's disease and other dementias are associated
with neurofibrillary tangles and neurodegeneration. Here we describe a mouse (TauD35) …

Alzheimer's disease (AD) is becoming increasingly common as the global population ages.
The World Health Organization (WHO) estimates that 1 billion people were over the age of …

Background Immunologic abnormalities have been described in peripheral blood and
central nervous system of patients suffering from Alzheimer's disease (AD), yet their role in …

Alzheimer's disease (AD) mouse models have proven to be an invaluable tool for deepening
our understanding of disease mechanisms and for developing therapeutics. However, one …

Beschreibungen: Alzheimer's disease (AD) is a complex neurodegenerative disorder with
multiple features. With the help of animal models, the AD physiopathology is starting to be …

Alzheimer's disease (AD) is the most common type of dementia. The pathological
characterizations of AD are the depositions of a peptide called amyloid beta and of hyper …

Alzheimer's disease (AD) is one of the categories of neurodegenerative diseases
characterized by a conformational change of a normal protein into a pathological conformer …

The necessity for a deeper understanding of neurological diseases such as Alzheimer's
disease (AD) that increase in frequency as a function of age has become of paramount …

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by memory loss
and personality changes, eventually leading to dementia. The pathological hallmarks of AD …